Flavahan WA, Gaskell E, Bernstein BE. Epigenetic plasticity and the hallmarks of cancer. Science. 2017 Jul 21;357(6348).
Gaskell E. From mechanism to observation and back again. Mol Cell. 2016;62(5):649.
Emambokus N, Gaskell E, Granger A, et al. Women in Science. Cell Metab. 2016;23(5):747–748..
Liz Gaskell, Ph.D.
The mission of the Broad Epigenomics Program is a comprehensive understanding of the regulators & epigenetic mechanisms that control genome function in health & disease. Gaskell works on the scientific planning, organization, and execution of the Epigenomics Program projects. More generally, she also works with the core members and collaborators to chart the long-term scientific course of the program. She also manages the program’s community-building and outreach activities, including organizing the joint cell circuits and epigenomics weekly seminar series with Orit Rozenblatt-Rosen. Additionally, she supports research projects in Bernstein’s groups at Massachusetts General Hospital and the Broad Institute.
Prior to joining the Broad Institute in July of 2016, Gaskell worked in scientific publishing, first as an editor for Genome Biology and then for Molecular Cell, where she specialized in genome regulation, chromatin biology, systems biology, and DNA and RNA metabolism. She also engaged in outreach work to make the process of scientific publishing more transparent, particularly for trainees and new PIs. She therefore has extensive experience in life science publishing from both the subscription and open-access models. She also has run several successful international scientific meetings on topics from ubiquitin signaling to gender in science.
Gaskell holds a Ph.D. in biochemistry from the University of Leeds and a B.Sc. (Hons) in biochemistry with applied molecular biology from the University of Manchester.
Contact Liz Gaskell at email@example.com.